Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Novartis HQ

Novartis to cut 2,000 jobs

October 25, 2011 Manufacturing and Production, Research and Development

Novartis will cut around 2,000 jobs is the US and Switzerland as part of additional cost saving measures. The positions …
News

David Meeker appointed as chief executive of Genzyme

October 25, 2011 Research and Development, Sales and Marketing Genzyme, Sanofi

Sanofi has appointed David Meeker as chief executive of its new biotech acquisition Genzyme. He will report to Christopher Viehbacher, …
Appointment

New venture a ‘game-changer’ for pharma

October 25, 2011 Research and Development Sir Christopher Evans, drug development

Sir Christopher Evans is looking to create a new venture that aims to improve on the drug development productivity of …
News
Sanofi HQ

Sanofi’s Lemtrada beats Rebif in MS study

October 25, 2011 Research and Development, Sales and Marketing Lemtrada, Sanofi

Sanofi’s investigational multiple sclerosis drug Lemtrada has beaten Rebif in a late-stage trial. The Phase III results show that 78% …
News

Risk Based Inspections for good pharmacovigilance practice

October 24, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Recently in the UK there has been a move towards risk-based inspection programmes.  The scope, frequency and depth of MHRA …
News
Press release
Lab image

Does drug development deliver on its promises?

October 24, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, R&D

I am always guided by the motto of the Royal Society, ‘Nullius in Verba’. This means, with typical Latin brevity: …
Feature
Merck image

Merck to invest $1billion in Singapore R&D and manufacturing

October 24, 2011 Manufacturing and Production, Research and Development

Singapore has reinforced its position as a major pharmaceutical hub for the Asia-Pacific region with the news that Merck is …
News

Bristol-Myers Squibb makes three senior management changes

October 24, 2011 Medical Communications, Research and Development, Sales and Marketing BMS

BMS has made three changes to its senior management with Giovanni Caforio promoted to president of US pharmaceuticals and Charles …
Appointment
Depakote

Abbott to pay $1.3 billion for Depakote lawsuits

October 24, 2011 Research and Development, Sales and Marketing Abbott, Depakote

 
News

Merck Serono returns Parkinson’s drug rights to Newron

October 24, 2011 Research and Development, Sales and Marketing Merck Serono, Newron

Merck Serono has returned the rights to the Parkinson’s disease drug safinamide back to Newron. The decision comes after the …
News

Abbott spin-off could attract mega merger

October 21, 2011 Research and Development, Sales and Marketing Abbott, Bayer, Humira, Merck, Roche

Abbott’s new spin-off pharma firm could attract a lot of attention from big pharma looking to sure up their portfolios. …
News
abpi

UK research cannot rest on its laurels, warns ABPI

October 21, 2011 Medical Communications, Research and Development ABPI, NHS, R&D

The ABPI has warned that the UK must continue to attract investment for research, or risk being superseded by emerging …
News
Abbott

Abbott to split into two separate companies

October 20, 2011 Manufacturing and Production, Research and Development, Sales and Marketing Abbott, Abbott Laboratories

Abbott’s management has decided to split the company into two separate entities in order to give shareholders a ‘distinct investment …
News
GSK

Rumours abound on GSK-HGS takeover bid

October 20, 2011 Research and Development, Sales and Marketing Benlysta, GSK, HGS

Rumours are gathering pace that GlaxoSmithKline may launch a takeover bid for struggling US firm Human Genome Sciences. British tabloid …
News
Herceptin image

Injectable Herceptin proves its worth

October 20, 2011 Research and Development, Sales and Marketing Herceptin, Roche

An injectable version of Roche’s breast cancer drug Herceptin compares favourably to the standard intravenous infusion, according to new research. …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025